相似文献
1
Vesiculobullous eruption in a patient receiving psoralen ultraviolet A (PUVA) treatment for prurigo nodules: a case of PUVA-aggravated pemphigoid nodularis.
Clin Exp Dermatol. 2017 Oct;42(7):833-835. doi: 10.1111/ced.13172. Epub 2017 Jun 9.
2
Bullous pemphigoid possibly induced by psoralen plus ultraviolet A therapy.
Photodermatol Photoimmunol Photomed. 1995 Oct-Dec;11(5-6):185-7. doi: 10.1111/j.1600-0781.1995.tb00166.x.
3
Acquired dermal melanocytosis induced by psoralen plus ultraviolet A therapy.
Acta Derm Venereol. 2012 Nov;92(6):691-2. doi: 10.2340/00015555-1282.
4
Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients.
Photodermatol Photoimmunol Photomed. 2004 Dec;20(6):289-96. doi: 10.1111/j.1600-0781.2004.00123.x.
5
Delayed onset of bullous pemphigoid after PUVA and sunlight treatment of psoriasis.
Cutis. 1982 Nov;30(5):621-4.
6
PUVA-induced Bullous Pemphigoid in Psoriasis.
Acta Dermatovenerol Croat. 2016 Aug;24(3):214-7.
7
Psoralen plus ultraviolet A-induced bullous pemphigoid.
J Drugs Dermatol. 2008 Jul;7(7):695-6.
8
Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study.
Photodermatol Photoimmunol Photomed. 2005 Dec;21(6):281-6. doi: 10.1111/j.1600-0781.2005.00183.x.
9
High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
J Invest Dermatol. 2003 Apr;120(4):676-82. doi: 10.1046/j.1523-1747.2003.12085.x.
10
[Bullous pemphigoid related to PUVA therapy: two further cases].
Actas Dermosifiliogr. 2006 Sep;97(7):444-7. doi: 10.1016/s0001-7310(06)73437-8.
引用本文的文献
1
Pemphigoid Nodularis Induced by Long-Term Use of Dipeptidyl Peptidase-4 Inhibitors.
Indian J Dermatol. 2023 Jan-Feb;68(1):104-105. doi: 10.4103/ijd.ijd_632_22.
2
Case Report: Pemphigoid Nodularis-Five Patients With Many Years of Follow-Up and Review of the Literature.
Front Immunol. 2022 Apr 12;13:885023. doi: 10.3389/fimmu.2022.885023. eCollection 2022.
3
The Immunogenetics of Autoimmune Blistering Diseases.
Adv Exp Med Biol. 2022;1367:173-212. doi: 10.1007/978-3-030-92616-8_8.
4
Treatment-resistant prurigo nodularis: challenges and solutions.
Clin Cosmet Investig Dermatol. 2019 Feb 28;12:163-172. doi: 10.2147/CCID.S188070. eCollection 2019.
5
Pemphigoid nodularis - rare presentation of bullous pemphigoid: A case report and literature review.
Exp Ther Med. 2019 Feb;17(2):1132-1138. doi: 10.3892/etm.2018.7057. Epub 2018 Dec 5.
6
The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.
Front Med (Lausanne). 2018 Jul 10;5:201. doi: 10.3389/fmed.2018.00201. eCollection 2018.
7
Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Clin Rev Allergy Immunol. 2018 Feb;54(1):26-51. doi: 10.1007/s12016-017-8633-4.
本文引用的文献
1
BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?
Br J Dermatol. 2014 Aug;171(2):212-9. doi: 10.1111/bjd.12936. Epub 2014 Aug 5.
2
Pemphigoid nodularis (non-bullous): a clinicopathological study of five cases.
Br J Dermatol. 2002 Aug;147(2):343-9. doi: 10.1046/j.1365-2133.2002.04754.x.
3
Pemphigoid nodularis: a report of three cases and review of the literature.
Br J Dermatol. 1997 Mar;136(3):398-401.
4
Bullous pemphigoid possibly induced by psoralen plus ultraviolet A therapy.
Photodermatol Photoimmunol Photomed. 1995 Oct-Dec;11(5-6):185-7. doi: 10.1111/j.1600-0781.1995.tb00166.x.
5
PUVA-induced blisters, complement deposition, and damage to the dermoepidermal junction.
Arch Dermatol. 1987 Nov;123(11):1471-7.
6
Bullous pemphigoid induced by PUVA therapy. Is this the aetiology of the acral bullae produced during PUVA treatment?
Br J Dermatol. 1978 Dec;99(6):709-13. doi: 10.1111/j.1365-2133.1978.tb07067.x.
Zotero 插件